Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
22.38
+0.19 (0.86%)
Sep 17, 2026, 4:00 PM EDT - Market closed
Collegium Pharmaceutical Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Initiates $45 | Buy | Initiates | $45 | +101.07% | Sep 9, 2026 |
Alexander Xenakis Truist Financial No rating | Truist Financial | Buy Initiates $58 → $49 | Buy | Initiates | $58 → $49 | +118.95% | Sep 9, 2026 |
| Barclays | Barclays | Buy Reiterates $56 → $48 | Buy | Reiterates | $56 → $48 | +114.48% | Aug 19, 2026 |
| Piper Sandler | Piper Sandler | Hold Reiterates $45 → $43 | Hold | Reiterates | $45 → $43 | +92.14% | Aug 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $60 | Buy | Reiterates | $60 | +168.10% | Aug 7, 2026 |
| Needham | Needham | Buy Maintains $56 → $46 | Buy | Maintains | $56 → $46 | +105.54% | Aug 6, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $51 | Buy | Maintains | $51 | +127.88% | Mar 20, 2026 |